Consort Medical PLC (LSE:CSRN) - Share price - Overview

Stock Report

Consort Medical PLC CSRN

Last Price
£-

Day Change
-|-%

As of -
- | GBP
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap538.90Mil
52-Wk Range-
Yield %-
ISINGB00BQJZTM21
Volume-
P/E-
P/S-
P/CF-

Share Price

Total Returns 28/09/2015

 Chg (%)  
More ...
Consort Medical PLC0.00 
FTSE 100 TR GBP1.43
 
Financials
201520162017
More ...
Income Statement
Turnover184.83276.91294.00
Operating Profit8.1615.9626.30
Net Profit6.2615.9722.60
Reported EPS15.2032.3045.70
Balance Sheet
Current Assets141.94110.90122.20
Non Current Assets329.83334.86338.90
Total Assets471.77445.76461.10
Current Liabilities221.93178.78181.80
Total Liabilities271.28236.61249.00
Total Equity200.49209.15212.10
Cash Flow
Operating Cash Flow18.0546.7546.90
Net Change in Cash20.35-28.393.50
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
201837.5862.8429.4717.430.5921.051.92
201941.3867.547.4816.212.1721.892.00
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
07/08/2017PurchaseMr. Jon Glenn1,099.9115165.00
07/08/2017PurchasePaul Hayes1,099.9113143.00
07/07/2017PurchaseMr. Jon Glenn1,029.0015154.00
20/06/2017Sale of Option SharesMr. Jon Glenn1,076.0077,649835,503.00

Company Profile

Consort Medical PLC is mainly a medical device manufacturer. Its core products include drug delivery devices such as inhaler, auto-injector, nasal and ocular technologies. It also supplies drugs such as active pharmaceutical ingredients.

Sector

Medical Devices

Market Position

443 of 1845 Companies

Index

FTSE Small Cap ,FTSE techMARK Focus ,FTSE techMARK All Share ,FTSE All Share

Outlook

(28/07/2017) ch - "The board remains confident about the prospects for the group"

Next Event 06/09/2017

Next AGM
Ratios
CompSecMkt
More ...
PER (E)17.0520.5216.76
Div Yld (E)1.951.614.16
PEG (E)0.791.171.08
ROCE12.7919.3210.63
Op Mrgn8.745.923.95
EPS Grwth21.7349.2423.34
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy5
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Peter Fellner
Chief Executive OfficerMr. Jon Glenn
Chief Financial OfficerPaul Hayes
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.